Naloxone: Recognizing an Opioid Overdose and Responding

Naloxone is available in community settings as nasal spray and other formulations. It can restore breathing in someone experiencing an opioid overdose, which makes it a time-sensitive rescue medicine. Pharmacy technicians may encounter prescriptions, over-the-counter naloxone products, insurance questions, or a person reporting an active emergency. The response depends on the situation: an overdose is an emergency, while routine product questions can be referred to the pharmacist.

Recognize the possible overdose

An opioid overdose can cause very slow, shallow, irregular, or stopped breathing; inability to wake; limpness; blue, gray, or pale lips and nails; and pinpoint pupils. A person may make choking, gurgling, or snoring sounds. Do not assume that someone is simply asleep or intoxicated when breathing is abnormal and they cannot be awakened. If the situation is uncertain but overdose is possible, treat it as an emergency and get help immediately.

Naloxone reverses opioid effects, including effects from prescription opioids and illicitly manufactured fentanyl. It does not reverse non-opioid sedatives such as benzodiazepines, and a person may have taken several substances. Lack of a dramatic response to the first dose does not establish that opioids were absent. Emergency responders should assess the person and provide further care.

Core response sequence

Call 911 or activate the local emergency response system as soon as an overdose is suspected. Give naloxone promptly if it is available and the responder is able to use it, following the specific device instructions. Many ready-to-use nasal products are administered as one spray into one nostril; if the person does not respond or responds and then relapses, additional doses may be needed at intervals stated in that product’s labeling while help is on the way. Product instructions can differ, so use the package directions and training.

Support breathing and circulation as trained and instructed by emergency dispatchers. If the person is breathing but not fully awake, place them on their side in the recovery position when safe to do so, to reduce choking risk. Stay with them and watch for a return of overdose signs. Naloxone can wear off while the opioid remains active, so awakening is not a reason to cancel emergency services or leave the person alone.

Naloxone may trigger acute opioid withdrawal in a person who is physically dependent. They may wake abruptly, feel distressed, vomit, sweat, shake, or become agitated. These effects do not mean that naloxone should be withheld during a life-threatening overdose. Keep the scene safe, do not argue or restrain unnecessarily, and follow emergency dispatcher instructions.

Use the exact product correctly

Ready-to-use nasal sprays are designed for emergency use without assembling a syringe. The user should read the device directions before an emergency, because critical actions happen under stress. A nasal device is generally placed in one nostril and pressed according to its instructions; it should not be primed or test-sprayed unless the product labeling specifically directs it. Injectable naloxone products have different preparation and administration requirements and may require training.

Store naloxone according to its label and keep it accessible. Some products should be protected from light and kept within a stated temperature range; do not rely on a car glove compartment exposed to heat or freezing conditions. Check expiration dates and replace expired, damaged, or used devices. A product that may have been exposed to unsuitable conditions should be reviewed with a pharmacist. The package insert governs storage, repeat-dose timing, and device use.

Pharmacy access and stigma-sensitive service

FDA-approved naloxone nasal spray products are available without a prescription in the United States, though local availability, age requirements, insurance coverage, and state rules can affect how a patient obtains a product. Pharmacies may also dispense prescription products. If someone asks whether they can obtain naloxone, technicians can identify the available product and route questions about price, coverage, or training to the pharmacist without implying that the person is misusing opioids.

Naloxone can be useful for anyone who may witness an overdose, including family members, friends, and caregivers. A nonjudgmental interaction encourages people to keep the medicine nearby and learn how to use it. Avoid assumptions based on appearance, diagnosis, or the prescription history. Protect privacy, speak discreetly, and let the pharmacist handle clinical counseling and local harm-reduction resources.

A counter emergency versus a routine question

If a customer collapses in or near the pharmacy and is unresponsive with abnormal breathing, summon emergency help immediately and alert the pharmacist. Follow the site emergency plan, retrieve naloxone if authorized and available, and follow training or dispatcher directions. Do not spend time searching the insurance system, debating whether the person has a prescription, or waiting for certainty. If the question is instead about how to carry a device, where it is stocked, or when it expires, involve the pharmacist for product-specific instructions.

Prepare before an emergency

The person most likely to use naloxone should know where it is kept and how to operate the particular device. A pharmacist can demonstrate the product and answer questions about carrying it, replacement, or local training. Check the expiration date periodically and replace a used device. Keep it where a bystander can find it quickly, while following storage instructions and protecting it from children when appropriate.

An overdose response can be frightening. Tell emergency dispatchers what was given, how many doses were used, and when the person’s breathing or alertness changed. If the person refuses care after waking, remain with them and follow dispatcher instructions; overdose can recur. Do not assume the person is safe because they can speak or walk briefly. Responders need accurate information about suspected substances and naloxone administration.

PTCE points to retain

• Unresponsiveness plus slow, shallow, or absent breathing can signal opioid overdose.
• Activate emergency services and administer available naloxone according to its product instructions.
• Naloxone’s effect may wear off; continued observation and emergency evaluation are essential.
• Repeat dosing may be needed; use the interval in the specific product labeling and training.
• Technicians follow emergency protocols and refer product-specific counseling to the pharmacist.